Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

MHS leaders discuss future of military medicine during AMSUS panel

Image of Military personnel, wearing masks, standing in a line in front of flags. The military’s top medical leaders pose for a photo after presenting Senior Leadership Panel at Defense during the 2020 Association of Military Surgeons of the United States’ annual meetings. (Photo Courtesy of Office of the Army Surgeon General.)

The top leaders in military medicine discussed the future of the Military Health System and its impact on mission readiness during a Senior Leadership Panel Dec. 8 at the annual meeting of The Society of Federal Health Professionals (AMSUS).

The virtual event was moderated by Thomas McCaffery, assistant secretary of defense for health affairs, and the panelists included Lt. Gen. (Dr.) Ronald Place, director of the Defense Health Agency; Air Force Brig. Gen. (Dr.) Paul Friedrichs, Joint Staff surgeon; the surgeons general of the Army and Navy, Lt. Gen. R. Scott Dingle and Rear Adm. Bruce Gillingham; deputy surgeon general of the Air Force, Maj. Gen. Sean Murphy, and Uniformed Service University of the Health Sciences President Dr. Richard Thomas.

Place began the discussion by saying that, despite setbacks caused by the COVID-19 pandemic, the transfer in management of more than 700 Army, Navy and Air Force hospitals, medical and dental clinics to the DHA is on track.

“Some important dialogue, feedback loops, improvements, etc. were made during the pause of transition activities,” Place said. “So, there are some improvements that have been made in the intervening several months as well.”

Place said the DHA structure allows them to provide the best treatment options for MHS beneficiaries by moving resources, including personnel, equipment, funding, and capabilities, within a given geographic area.

“The patient-facing side of it is a standardization of practices and procedures such that, it's not a different way to make an appointment at each of the different MTFs, it's a single way. In fact, it's a single appointment line for all of them,” Place said. “It's the way that the pharmacies work, the way that the laboratories work. It's all standardized such that it's easier and more intuitive for each of the patients.”

For Dingle, readiness is the key issue during the transition.

“That readiness includes everything from recruiting, organizing, training and equipment, to making sure that all of those health care professionals are ready to deploy to support tomorrow's battles,” Dingle said.

Gillingham, Dingle’s Navy counterpart, agreed. He also said COVID-19 has highlighted the critical impact of the MHS to readiness of U.S. military forces.

“I think COVID has dramatically emphasized the role that the military has in place, not only in the care delivered in the MTF, but in the installation support,” Gillingham said. “In our case, to keep the fleet or the Marine Corps healthy and ready.”

Thomas also said he thinks the efficiency a “system of systems” created by the MHS has shown, bringing together elements from military and VA hospitals for instance, has been highlighted by the pandemic.

“Although we are at the highest level of hospitalizations in the pandemic, we’re at the lowest level of taskings for military personnel because of these partnerships,” Thomas said. “And the way ahead for us I hope will be to continue to leverage those partnerships and to look for opportunities, not just in a pandemic but to work more closely, sustaining currency and readiness, or any of the other tasks.”

From a Defense Health Agency perspective, Place said the ability to use the interoperability created by the DHA has proved invaluable. Just one example of this is the collection of COVID-19 convalescent plasma. Patients from facilities throughout the MHS contributed to the Secretary of Defense’s goal of collecting 10,000 units of CCP between June and September of this year. Approximately 3,000 donors, all of whom had recovered from the virus, contributed to the campaign.

Place said the integration of the Armed Services blood system and each of the individual services’ blood programs allowed them to locate potential donors and make CCP available across the enterprise.

The improvement of processes is also an integral part of the transition, continuity, and planning operations for the future.

“I think that's been very helpful to all of us,” Thomas said. “I think the importance of continuity of operations planning has been paramount.”

Throughout the event, the panelists agreed that the focus is on the mission and making sure the health system is positioned to meet that mission.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

  • Identification #: 22-006
  • Date: 8/18/2022
  • Type: Memorandums
  • Topics: COVID-19

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

  • Identification #: DHA-IPM 20-004
  • Date: 6/16/2022
  • Type: DHA Interim Procedures Memorandum
  • Topics: COVID-19

Continuing Implementation for Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System organizational reform required by law, extending the authority, direction and control of all military hospitals and clinics not currently under Defense Health Agency authority to the DHA, to include military hospitals and clinics in overseas areas.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

  • Identification #: 21-004
  • Date: 11/3/2021
  • Type: Memorandums
  • Topics: COVID-19

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

  • Identification #: 6025.01
  • Date: 5/10/2021
  • Type: DHA Procedural Instruction
  • Topics: COVID-19

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: COVID-19

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: COVID-19

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

  • Identification #: N/A
  • Date: 12/31/2020
  • Type: Memorandums
  • Topics: COVID-19

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

  • Identification #: N/A
  • Date: 12/17/2020
  • Type: Memorandums
  • Topics: COVID-19

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

  • Identification #: N/A
  • Date: 12/8/2020
  • Type: Directives
  • Topics: COVID-19

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Date: 12/7/2020
  • Type: Memorandums
  • Topics: COVID-19

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: COVID-19

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: COVID-19

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

Page 1 of 1 , showing items 1 - 14
Refine your search
Last Updated: December 07, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery